<![CDATA[In the final episode, “Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy,” David Walling, PhD, explored how these findings add to the evolving evidence base for Cobenfy in schizophrenia, and what questions remain for future research.]]>